Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease-Reference-Cited by-同舟云学术

Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease

Published:2010-10-07 Issue:1 Volume:96 Page:128-133
ISSN:0390-6078
Container-title:Haematologica
language:en
Short-container-title:Haematologica

Author:

Andreani M.,Testi M.,Gaziev J.,Condello R.,Bontadini A.,Tazzari P. L.,Ricci F.,De Felice L.,Agostini F.,Fraboni D.,Ferrari G.,Battarra M.,Troiano M.,Sodani P.,Lucarelli G.

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of the Conditioning Regimen for Autologous and Ex Vivo Genetically Modified Hematopoietic Stem Cell-based Therapies: Recommendations from the ISCT Stem Cell Engineering Committee;Cytotherapy;2024-09

2. Favorable outcome of non‐myeloablative allogeneic transplantation in adult patients with severe sickle cell disease: A single center experience of 200 patients;American Journal of Hematology;2024-03-15

3. Mixed donor chimerism following stem cell transplantation for sickle cell disease;Current Opinion in Hematology;2023-09-01

4. Recent results of hematopoietic stem cell transplantation for thalassemia with busulfan-based conditioning regimen in France: improved thalassemia free survival despite frequent mixed chimerism. A retrospective study from the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC);Bone Marrow Transplantation;2023-08-04

5. In vivo hematopoietic stem cell modification by mRNA delivery;Science;2023-07-28